Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Transient cerebral ischaemia alters mesenteric arteries in hypertensive rats, Limited reversal despite suberoylanilide hydroxamic acid cerebroprotection

  • Díaz Pérez, Andrea|||0009-0008-2215-6344
  • Lope-Piedrafita, Silvia|||0000-0002-8127-6425
  • Pérez, Belén|||0000-0001-5801-1704
  • Vázquez-Sufuentes, Paula|||0009-0001-3369-9087
  • Rodriguez-Garcia, Maria
  • Briones, Ana|||0000-0001-8218-5579
  • Navarro, X. (Xavier)|||0000-0001-9849-902X
  • Penas Pérez, Clara|||0000-0003-0554-3832
  • Jiménez Altayó, Francesc|||0000-0002-9034-2041
Stroke induces brain injury, especially severe in hypertensive patients, and elevates mortality rates through non-neurological complications. However, the potential effects of a transient ischaemic episode on the peripheral vasculature of hypertensive individuals remain unclear. We investigated whether transient cerebral ischaemia (90 min)/reperfusion (1 or 8 days) induces alterations in mesenteric resistance artery (MRA) properties in adult male spontaneously hypertensive rats (SHR). In addition, we assessed whether the reported cerebroprotective effects of suberoylanilide hydroxamic acid (SAHA; 50 mg/kg; administered intraperitoneally at 1, 4, or 6 h after reperfusion onset) extend over several days and include beneficial effects on MRAs. Functional and structural properties of MRAs were examined at 1- and 8-days post-stroke. Nuclei distribution, collagen content, and oxidative stress were assessed. Ischaemic brain damage was evaluated longitudinally using magnetic resonance imaging. Following stroke, MRAs from SHR exhibited non-reversible impaired contractile responses to the thromboxane A receptor agonist U46619. Stroke increased the MRA cross-sectional area, wall thickness, and wall/lm ratio due to augmented collagen deposition. These changes were partially sustained 8 days later. SAHA did not improve U46619-induced contractions but mitigated stroke-induced oxidative stress and collagen deposition, preventing MRA remodelling at 24 h of reperfusion. Furthermore, SAHA induced sustained cerebroprotective effects over 8 days, including reduced brain infarct and oedema, and improved neurological scores. However, SAHA had minimal impact on chronic MRA contractile impairments and remodelling. These findings suggest that stroke causes MRA changes in hypertensive subjects. While SAHA treatment offers sustained protection against brain damage, it cannot fully restore MRA alterations.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Transient cerebral ischaemia alters mesenteric arteries in hypertensive rats: Limited reversal despite suberoylanilide hydroxamic acid cerebroprotection

  • Díaz-Pérez, Andrea
  • Lope-Piedrafita, Silvia
  • Pérez, Belén
  • Vázquez-Sufuentes, Paula
  • Rodríguez García, María
  • Briones, Ana M
  • Navarro, Xavier
  • Penas, Clara
  • Jiménez-Altayó, Francesc
Stroke induces brain injury, especially severe in hypertensive patients, and elevates mortality rates through non-neurological complications. However, the potential effects of a transient ischaemic episode on the peripheral vasculature of hypertensive individuals remain unclear. We investigated whether transient cerebral ischaemia (90 min)/reperfusion (1 or 8 days) induces alterations in mesenteric resistance artery (MRA) properties in adult male spontaneously hypertensive rats (SHR). In addition, we assessed whether the reported cerebroprotective effects of suberoylanilide hydroxamic acid (SAHA; 50 mg/kg; administered intraperitoneally at 1, 4, or 6 h after reperfusion onset) extend over several days and include beneficial effects on MRAs. Functional and structural properties of MRAs were examined at 1- and 8-days post-stroke. Nuclei distribution, collagen content, and oxidative stress were assessed. Ischaemic brain damage was evaluated longitudinally using magnetic resonance imaging. Following stroke, MRAs from SHR exhibited non-reversible impaired contractile responses to the thromboxane A2 receptor agonist U46619. Stroke increased the MRA cross-sectional area, wall thickness, and wall/lm ratio due to augmented collagen deposition. These changes were partially sustained 8 days later. SAHA did not improve U46619-induced contractions but mitigated stroke-induced oxidative stress and collagen deposition, preventing MRA remodelling at 24 h of reperfusion. Furthermore, SAHA induced sustained cerebroprotective effects over 8 days, including reduced brain infarct and oedema, and improved neurological scores. However, SAHA had minimal impact on chronic MRA contractile impairments and remodelling. These findings suggest that stroke causes MRA changes in hypertensive subjects. While SAHA treatment offers sustained protection against brain damage, it cannot fully restore MRA alterations., This work was supported by grants: i) PID2020–113634RB-C22/AEI/10.13039/501100011033 and PID2019–108496RA-I00/AEI/10.13039/501100011033 from Ministerio de Ciencia e Innovación and Agencia Estatal de Investigación of Spain; ii) 2021 SGR 00969 from Generalitat de Catalunya; iii) Project NEUROGRAPH, GraphCAT: Comunitat Emergent de Grafè a Catalunya (grant 001-P-001702), by FLAG-ERA JTC 2021 project RESCUEGRAPH, by the Agencia Estatal de Investigación of Spain projects PCI2021–122075; iv) RICORS TERAV (grant RD21/0017/008); and v) CIBERNED (grant CB06/05/1105) from the Instituto de Salud Carlos III of Spain, co-funded by European Union (NextGenerationEU, Recovery, Transformation and Resilience Plan)., Peer reviewed
Dipòsit Digital de Documents de la UAB
Datos de investigación Set de datos (Dataset)

Raw data from Palomés-Borrajo et al, Journal of Neuroscience Research, 2021

  • Palomés Borrajo, Georgina|||0000-0002-8217-2054
  • Navarro, X. (Xavier)|||0000-0001-9849-902X
  • Penas Pérez, Clara|||0000-0003-0554-3832
This dataset contains the recordings used for the statistical analysis collected in the article "BET protein inhibition in macrophages enhances dorsal root ganglion outgrowth in female mice", submitted to the Journal of Neuroscience Research. It contains numerical data of qPCRs and electrophysiological recordings derived from the in vivo experiments, as well as information of neurite outgrowth of DRG explants, drug toxicity and Western Blots of the ex vivo research. Data is classified in several tabs according to the figures found in the paper.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

BET protein inhibition in macrophages enhances dorsal root ganglion neurite outgrowth in female mice

  • Palomés Borrajo, Georgina|||0000-0002-8217-2054
  • Navarro, X. (Xavier)|||0000-0001-9849-902X
  • Penas Pérez, Clara|||0000-0003-0554-3832
Peripheral nerve regeneration is limited after injury, especially in humans, due to the large distance the axons have to grow in the limbs. This process is highly dependent on the expression of neuroinflammatory factors produced by macrophages and glial cells. Given the importance of the epigenetic BET proteins on inflammation, we aimed to ascertain if BET inhibition may have an effect on axonal outgrowth. For this purpose, we treated female mice with JQ1 or vehicle after sciatic nerve crush injury and analyzed target reinnervation. We also used dorsal root ganglion (DRG) culture explants to analyze the effects of direct BET inhibition or treatment with conditioned medium from BET-inhibited macrophages. We observed that although JQ1 produced an enhancement of IL-4, IL-13, and GAP43 expression, it did not have an effect on sensory or motor reinnervation after crush injury in vivo. In contrast, JQ1 reduced neurite growth when interacting directly with DRG neurons ex vivo, whereas conditioned medium from JQ1-treated macrophages promoted neurite outgrowth. Therefore, BET-inhibited macrophages secrete pro-regenerative factors that induce neurite outgrowth, and that may counteract the direct inhibition of BET proteins in neurons in vivo. Finally, we observed an activation of the STAT6 pathway in DRG explants treated with conditioned medium from JQ1-treated macrophages. In conclusion, this study demonstrates that BET protein inhibition in macrophages provides a mechanism to enhance axonal outgrowth. However, specific targeting of BET proteins to macrophages will be needed to efficiently enhance functional recovery after nerve injury.